With developments in the molecular genotyping of LC (especially NSCLC), more than 50 tumor-associated RTKs have been identified, such as EGFR, c-MET, ROS1, RET, and ALK. The gene discussed is EGFR; the disease is laryngotracheoesophageal cleft.